Conestoga Capital Advisors’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-745,475
| Closed | -$59.5M | – | 147 |
|
|
2021
Q1 | $59.5M | Sell |
745,475
-52,006
| -7% | -$4.06M | 0.9% | 45 |
|
|
2020
Q4 | $62.9M | Buy |
797,481
+8,327
| +1% | +$488K | 1% | 45 |
|
|
2020
Q3 | $34.7M | Buy |
789,154
+26,795
| +4% | +$1.32M | 0.7% | 46 |
|
|
2020
Q2 | $33.7M | Buy |
762,359
+4,420
| +0.6% | +$165K | 0.73% | 48 |
|
|
2020
Q1 | $27.2M | Sell |
757,939
-918,264
| -55% | -$52.2M | 0.8% | 47 |
|
|
2019
Q4 | $119M | Sell |
1,676,203
-19,203
| -1% | -$1.39M | 2.86% | 4 |
|
|
2019
Q3 | $127M | Sell |
1,695,406
-6,883
| -0.4% | -$583K | 3.25% | 3 |
|
|
2019
Q2 | $137M | Buy |
1,702,289
+456,805
| +37% | +$32.1M | 3.43% | 3 |
|
|
2019
Q1 | $83.3M | Buy |
1,245,484
+13,175
| +1% | +$998K | 2.32% | 16 |
|
|
2018
Q4 | $91.7M | Buy |
1,232,309
+247,592
| +25% | +$20.4M | 2.92% | 5 |
|
|
2018
Q3 | $90.7M | Buy |
984,717
+294,044
| +43% | +$28M | 2.31% | 11 |
|
|
2018
Q2 | $67.9M | Buy |
690,673
+40,250
| +6% | +$4.5M | 2.19% | 20 |
|
|
2018
Q1 | $72.5M | Sell |
650,423
-22,545
| -3% | -$2.53M | 2.78% | 10 |
|
|
2017
Q4 | $69.2M | Sell |
672,968
-64,086
| -9% | -$6.38M | 2.66% | 10 |
|
|
2017
Q3 | $69.4M | Buy |
737,054
+10,008
| +1% | +$790K | 3.07% | 3 |
|
|
2017
Q2 | $56.6M | Buy |
727,046
+65,910
| +10% | +$4.95M | 2.95% | 4 |
|
|
2017
Q1 | $53M | Buy |
661,136
+36,681
| +6% | +$2.92M | 3.2% | 3 |
|
|
2016
Q4 | $49.2M | Buy |
624,455
+1,905
| +0.3% | +$148K | 3.27% | 1 |
|
|
2016
Q3 | $48.5M | Buy |
622,550
+14,370
| +2% | +$1.04M | 3.33% | 3 |
|
|
2016
Q2 | $41.8M | Sell |
608,180
-122,815
| -17% | -$8.47M | 3.09% | 7 |
|
|
2016
Q1 | $52.2M | Buy |
730,995
+73,956
| +11% | +$4.64M | 3.52% | 4 |
|
|
2015
Q4 | $40.8M | Sell |
657,039
-292,126
| -31% | -$17.8M | 3.3% | 7 |
|
|
2015
Q3 | $53.8M | Sell |
949,165
-30,891
| -3% | -$1.64M | 4.31% | 1 |
|
|
2015
Q2 | $52.6M | Sell |
980,056
-13,775
| -1% | -$670K | 3.65% | 3 |
|
|
2015
Q1 | $47.2M | Sell |
993,831
-22,330
| -2% | -$988K | 3.23% | 6 |
|
|
2014
Q4 | $44M | Sell |
1,016,161
-41,065
| -4% | -$1.68M | 3.06% | 8 |
|
|
2014
Q3 | $36.3M | Buy |
1,057,226
+167,380
| +19% | +$5.91M | 2.66% | 9 |
|
|
2014
Q2 | $32.6M | Buy |
889,846
+445,846
| +100% | +$15.1M | 2.19% | 20 |
|
|
2014
Q1 | $15M | Buy |
+444,000
| New | +$14.6M | 0.95% | 43 |
|
Conestoga Capital Advisors's CMD Position: Q2 2021 in Review
Conestoga Capital Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 745,475 shares — an estimated $59.5M sold.
Conestoga Capital Advisors first reported a position in CMD in Q1 2014 and held it in 29 quarters. The position peaked at $137M in Q2 2019. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Conestoga Capital Advisors reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Conestoga Capital Advisors sold 745,475 Cantel Medical Corporation shares in Q2 2021, an estimated $59.5M.
- Conestoga Capital Advisors first reported a position in Cantel Medical Corporation in Q1 2014 and held it in 29 quarters.
- Conestoga Capital Advisors's Cantel Medical Corporation position peaked at $137M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Conestoga Capital Advisors's 13F filing for Q2 2021, filed 27 Jul 2021.